Dacomitinib
Dacomitinib | |
---|---|
Term | Dacomitinib |
Short definition | Dacomitinib - (pronounced) (DA-koh-MIH-tih feather) drug used to treat non-small cell lung cancer that has spread, has not yet been treated and has certain mutations (changes). EGFRGen. |
Type | Cancer terms |
Specialty | Oncology |
Language | English |
Source | NCI |
Comments |
Dacomitinib - (pronounced) (DA-koh-MIH-tih feather) drug used to treat non-small cell lung cancer that has spread, has not yet been treated and has certain mutations (changes). EGFRGen. It is also being studied in the treatment of other types of cancer. Dacomitinib blocks certain proteins that can help stop cancer cells from growing and kill them. It's a type of tyrosine kinase inhibitor. Also referred to as PF-00299804 and Vizimpro
External links
- Medical encyclopedia article on Dacomitinib
- Wikipedia's article - Dacomitinib
This WikiMD dictionary article is a stub. You can help make it a full article.
Languages: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
Urdu,
বাংলা,
తెలుగు,
தமிழ்,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
European
español,
Deutsch,
français,
русский,
português do Brasil,
Italian,
polski